Skip to Content
Merck
CN

G1875

β-Galactosidase from bovine liver

Grade III, lyophilized powder, ≥0.15 units/mg protein

Synonym(s):

β-D-Galactoside galactohydrolase

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

CAS Number:
UNSPSC Code:
12352204
NACRES:
NA.54
EC Number:
232-864-1
MDL number:
EC Number:
Specific activity:
≥0.15 units/mg protein
Biological source:
bovine liver
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

bovine liver

Quality Level

type

Grade III

form

lyophilized powder

specific activity

≥0.15 units/mg protein

composition

Protein, ≥40%

shipped in

wet ice

storage temp.

−20°C

Application

β-galactosidase was used in the production of a stabilized, single reagent for alcohol analysis.

Biochem/physiol Actions

β-galactosidase cleaves lactose into its monosaccharide components, glucose and galactose. It also catalyses the transglycosylation of glucose into allolactose, the inducer of β-galactosidase, in a feedback loop.

Other Notes

One unit will hydrolyze 1.0 μmole of o-nitrophenyl β-D-galactoside to o-nitrophenol and D-galactose per min at pH 7.3 at 37 °C.


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

低风险生物材料

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Stabilization of Analytical Enzymes Using a Novel Polymer-Carbohydrate System and the Production of a Stabilized, Single Reagent for Alcohol Analysis
Timothy D. Gibson, John Higgins, John R. Woodward
Analyst, 117, 1293-1297 (1992)
Screening of high-risk Gaucher disease patients using dried blood spots techniques.
Filippo Vairo et al.
Gene, 523(1), 114-115 (2013-04-10)
Natalya Chernichenko et al.
JAMA otolaryngology-- head & neck surgery, 139(2), 173-182 (2013-02-23)
To examine the therapeutic effects of an attenuated, replication-competent vaccinia virus (GLV-1h68) against a panel of 5 human salivary gland carcinoma cell lines. The susceptibility of 5 salivary gland carcinoma cell lines to infection and oncolysis by GLV-1h68 was assessed



Global Trade Item Number

SKUGTIN
G1875-10UN04061833628416
G1875-25UN04061832843704
G1875-50UN04061832843711